Cargando…

Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects

Clarithromycin (CLR) is a member of the macrolide antibiotic group. CLR has low systemic oral bioavailability and is a drug of class II of the Biopharmaceutical Classification System. In many studies, using nanoparticles (NPs) as a drug delivery system has been shown to increase the effectiveness an...

Descripción completa

Detalles Bibliográficos
Autores principales: Öztürk, A. Alper, Yenilmez, Evrim, Özarda, Mustafa Güçlü
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835525/
https://www.ncbi.nlm.nih.gov/pubmed/31600969
http://dx.doi.org/10.3390/polym11101632
_version_ 1783466692845764608
author Öztürk, A. Alper
Yenilmez, Evrim
Özarda, Mustafa Güçlü
author_facet Öztürk, A. Alper
Yenilmez, Evrim
Özarda, Mustafa Güçlü
author_sort Öztürk, A. Alper
collection PubMed
description Clarithromycin (CLR) is a member of the macrolide antibiotic group. CLR has low systemic oral bioavailability and is a drug of class II of the Biopharmaceutical Classification System. In many studies, using nanoparticles (NPs) as a drug delivery system has been shown to increase the effectiveness and bioavailability of active drug substances. This study describes the development and evaluation of poly (lactic-co-glycolic acid) (PLGA) NPs and chitosan (CS)-coated PLGA NPs for oral delivery of CLR. NPs were obtained by nanoprecipitation technique and characterized in detail, and the effect of three molecular weights (M(w1): 7.000–17.000, M(w2): 38.000–54.000, M(w3): 50.000–190.000) of PLGA and CS coating on particle size (PS), zeta potential (ZP), entrapment efficiency (EE%), and release properties etc. were elucidated. Gastrointestinal stability and cryoprotectant effect tests were performed on the NPs. The PS of the prepared NPs were in the range of 178 to 578 nm and they were affected by the M(w) and CS coating. In surface-modified formulations with CS, the ZP of the NPs increased significantly to positive values. EE% varied from 62% to 85%, depending upon the M(w) and CS coating. In vitro release studies of CLR-loaded NPs showed an extended release up to 144 h. Peppas–Sahlin and Weibull kinetic model was found to fit best for CLR release from NPs. By the broth microdilution test method, the antibacterial activity of the formulations was determined on Staphylococcus aureus (ATCC 25923), Listeria monocytogenes (ATCC 1911), and Klebsiella pneumoniae (ATCC 700603). The structures of the formulations were clarified by thermal (DSC), FT-IR, and (1)H-NMR analysis. The results showed that PS, ZP, EE%, and dissolution rates of NPs were directly related to the M(w) of PLGA and CS coating.
format Online
Article
Text
id pubmed-6835525
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68355252019-11-25 Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects Öztürk, A. Alper Yenilmez, Evrim Özarda, Mustafa Güçlü Polymers (Basel) Article Clarithromycin (CLR) is a member of the macrolide antibiotic group. CLR has low systemic oral bioavailability and is a drug of class II of the Biopharmaceutical Classification System. In many studies, using nanoparticles (NPs) as a drug delivery system has been shown to increase the effectiveness and bioavailability of active drug substances. This study describes the development and evaluation of poly (lactic-co-glycolic acid) (PLGA) NPs and chitosan (CS)-coated PLGA NPs for oral delivery of CLR. NPs were obtained by nanoprecipitation technique and characterized in detail, and the effect of three molecular weights (M(w1): 7.000–17.000, M(w2): 38.000–54.000, M(w3): 50.000–190.000) of PLGA and CS coating on particle size (PS), zeta potential (ZP), entrapment efficiency (EE%), and release properties etc. were elucidated. Gastrointestinal stability and cryoprotectant effect tests were performed on the NPs. The PS of the prepared NPs were in the range of 178 to 578 nm and they were affected by the M(w) and CS coating. In surface-modified formulations with CS, the ZP of the NPs increased significantly to positive values. EE% varied from 62% to 85%, depending upon the M(w) and CS coating. In vitro release studies of CLR-loaded NPs showed an extended release up to 144 h. Peppas–Sahlin and Weibull kinetic model was found to fit best for CLR release from NPs. By the broth microdilution test method, the antibacterial activity of the formulations was determined on Staphylococcus aureus (ATCC 25923), Listeria monocytogenes (ATCC 1911), and Klebsiella pneumoniae (ATCC 700603). The structures of the formulations were clarified by thermal (DSC), FT-IR, and (1)H-NMR analysis. The results showed that PS, ZP, EE%, and dissolution rates of NPs were directly related to the M(w) of PLGA and CS coating. MDPI 2019-10-09 /pmc/articles/PMC6835525/ /pubmed/31600969 http://dx.doi.org/10.3390/polym11101632 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Öztürk, A. Alper
Yenilmez, Evrim
Özarda, Mustafa Güçlü
Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects
title Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects
title_full Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects
title_fullStr Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects
title_full_unstemmed Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects
title_short Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects
title_sort clarithromycin-loaded poly (lactic-co-glycolic acid) (plga) nanoparticles for oral administration: effect of polymer molecular weight and surface modification with chitosan on formulation, nanoparticle characterization and antibacterial effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835525/
https://www.ncbi.nlm.nih.gov/pubmed/31600969
http://dx.doi.org/10.3390/polym11101632
work_keys_str_mv AT ozturkaalper clarithromycinloadedpolylacticcoglycolicacidplgananoparticlesfororaladministrationeffectofpolymermolecularweightandsurfacemodificationwithchitosanonformulationnanoparticlecharacterizationandantibacterialeffects
AT yenilmezevrim clarithromycinloadedpolylacticcoglycolicacidplgananoparticlesfororaladministrationeffectofpolymermolecularweightandsurfacemodificationwithchitosanonformulationnanoparticlecharacterizationandantibacterialeffects
AT ozardamustafaguclu clarithromycinloadedpolylacticcoglycolicacidplgananoparticlesfororaladministrationeffectofpolymermolecularweightandsurfacemodificationwithchitosanonformulationnanoparticlecharacterizationandantibacterialeffects